The Gillett Health Podcast

Dr. Gillett and James O'Hara dive into the world of GLP-1 medications, ranking their favorites. They discuss the controversial retatratide, weighing its promise against safety risks. Ozempic's history unveils rare but serious side effects, while tirzepatide emerges as a clinical favorite. The duo also compares older GLP-1s like exenatide and liraglutide, revealing insights on tolerability and patient suitability. They explore the challenges of dulaglutide and oral semaglutide, plus the potential of non-peptide oral candidates. Engaging and informative!

Dive into the latest dietary guidelines with a fresh take on the food pyramid! Discover the newfound emphasis on protein and the ongoing confusion around saturated fat and sodium. The hosts discuss the disconnect between recommendations and real-world eating habits, advocating for clarity and practicality in guidance. Listen as they break down tighter added sugar rules and critique the choices displayed on the pyramid. Get inspired to prioritize protein, fiber, and wholesome foods for a healthier lifestyle!

The hosts delve into the controversial realm of full-body MRIs, weighing their pros and cons. They discuss a troubling malpractice case involving missed arterial blockages and question the safety of direct-to-consumer scans. The conversation highlights the importance of clinical guidance and the potential role of AI in radiology. With concerns over transparency, they suggest alternatives that involve doctor-mediated models for more accurate assessments. They ultimately stress the need for comprehensive follow-up and advocacy to ensure patient safety.

Dr. Dan Bristow, an OB-GYN physician with expertise in hormone therapy, dives into the critical differences between bioidentical and synthetic hormones. He sheds light on the cautious stance of ACOG regarding compounded bioidentical hormones and discusses the nuances of various hormone formulations. The conversation also explores how the gut enzyme beta-glucuronidase may influence estrogen levels and conditions like PCOS and endometriosis. Dan recommends lifestyle changes, including diet and probiotics, to modulate this enzyme for better women's health outcomes.

Andy Kushner, an orthopedic physical therapist with over 20 years at Athletico, shares invaluable insights on pectoral tendon tears. He discusses his three-day rule for assessing injuries, the importance of early evaluation, and how to manage recovery effectively. Andy emphasizes building resilience, safe rehab practices, and when to safely return to activities like bench pressing. He also critiques extreme online exercise advice and highlights the need for tailored rehab strategies, especially in comparison to professional athlete recovery.

Dr. Gillett and James O'Hara discuss why DEXA scans are so important. For High-quality labs:► http://sagebio.com/For information on the Gillett Health clinic, lab panels, and health coaching:► https://GillettHealth.comFollow Gillett Health for more content from James and Kyle► https://instagram.com/gilletthealth► https://www.tiktok.com/@gilletthealth► https://twitter.com/gilletthealth► https://www.facebook.com/gilletthealthFollow Kyle Gillett, MD► https://instagram.com/kylegillettmdFollow James O’Hara, NP► https://Instagram.com/jamesoharanpFor 10% off Gorilla Mind products, including SIGMA: Use code “GH10”► https://gorillamind.com/For discounts on high-quality supplements►https://www.thorne.com/u/GillettHealth#health #muscle #fatloss #bonehealth #bodybuildingAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Exciting developments in hair loss treatment are on the horizon with a new medication, PP405, showing promising results. The hosts dive into how it targets scalp stem cells to potentially restore hair follicles. They discuss the implications of a 31% density increase and the importance of context in interpreting study data. Concerns about non-responders and the study's timeframe are raised, along with the caution against using unregulated compounds. Plus, they explore other topical options in the hair-loss arena!

Dr. Gillett and James O'Hara dive into President Trump's MRI, questioning its purpose and exploring the ethics of full-body scans. They discuss the downsides of routine screening, like false positives and the burden of incidental findings. Privacy concerns around public release of presidential health data are raised, along with debates on pricing transparency in medical imaging. The hosts advocate for cash-pay options and emphasize that routine MRIs aren't typically recommended, all while inviting listeners to share their own experiences.

The hosts rank anabolic steroids by health risk and benefits, using a tier-list method. They dive into testosterone sources and the pros and cons of compounded products. The conversation covers DHEA's unpredictable effects, nandrolone's anabolic profile, and the risks associated with oxandrolone. They discuss trenbolone's potency and harsh side effects, along with the limited availability of Primobolan. Additionally, listeners learn about the risks of Winstrol and the promise of SARMs versus street products.

Explore the controversial world of GLP-1s and their effects on health. The hosts tackle dramatic claims about GLP-1s accelerating aging, while cautioning against misuse by influencers. They emphasize the importance of strength training and protein intake to prevent muscle loss during weight loss. Discussing the limited data on children, they highlight potential risks for young users. The conversation pivots to individualized treatment and the mixed evidence on GLP-1s improving health outcomes in older adults, urging a tailored approach.